Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2018-10-02 | 2018-10-12 | 62864 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Resolved | 2019-09-25 | 2019-10-22 | 94731 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-02-13 | 2020-06-08 | 105994 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2020-06-10 | 2020-06-15 | 117339 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2022-01-07 | 2022-03-28 | 152295 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2022-01-21 | 2022-04-01 | 153262 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2022-02-25 | 2022-03-29 | 155597 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2022-02-25 | 2022-04-01 | 155600 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-03-15 | 131812 |
| APO-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2023-07-21 | 2023-08-18 | 199524 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-09-15 | 2023-12-01 | 204411 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-10-06 | 2023-12-01 | 206566 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2017-11-27 | 2018-05-24 | 30796 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2018-01-22 | 2018-05-01 | 36806 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2018-02-05 | 2018-07-03 | 38508 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2018-02-13 | 2018-05-01 | 39638 |
| APO-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2018-02-13 | 2018-05-01 | 39641 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2018-03-13 | 2018-07-18 | 42672 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2018-05-15 | 2018-11-27 | 49478 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2018-09-28 | 2018-11-30 | 62604 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |